^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Peritoneal Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + Paclical (micellar paclitaxel) (Tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Apealea in combination with carboplatin is indicated for the treatment of adult patients with first relapse of platinum‑sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.